<DOC>
	<DOCNO>NCT02251626</DOCNO>
	<brief_summary>To test hypothesis plasma intracellular coenzyme Q10 level decline burn injury ubiquinol supplementation increase plasma intracellular coenzyme Q10 level burn patient . To test hypothesis ubiquinol supplementation ameliorate mitochondrial dysfunction/disintegrity metabolic derangement , decrease circulate alarmins ( a.k.a . endogenous DAMPs ) burn patient compare placebo .</brief_summary>
	<brief_title>Assessing Bioavailability CoQ10 Supplementation Burn Patients</brief_title>
	<detailed_description>Based previous clinical study preliminary preclinical data , want test hypothesis plasma intracellular coenzyme Q10 level decrease burn injury coenzyme Q10 ( ubiquinol ) supplementation reverse ameliorate insulin resistance , metabolic derangement , mitochondrial dysfunction , increase circulate DAMPs burn patient . The aforementioned previous study preliminary data warrant small-scale clinical study evaluate coenzyme Q10 status , bioavailability efficacy coenzyme Q10 ( ubiquinol ) supplementation burn patient . Coenzyme Q10 ( ubiquinol ) supplementation could represent novel , safe low-cost strategy improve clinical outcome burn patient . We conduct randomize , double-blind , placebo-controlled intervention study anticipate enrollment 50 subject . Adult burn patient 5 % great total body surface area ( TBSA ) burn Massachusetts General Hospital ( MGH ) Burn Center approach consider study participation . All enrol patient randomized receive coenzyme Q10 ( ubiquinol ) supplementation placebo . Blood sample use evaluation coenzyme Q10 concentration , mitochondrial DNA copy number , non-mitochondrial DAMPs ( e.g. , cell-free total DNA ) , defective neutrophil migration .</detailed_description>
	<mesh_term>Burns</mesh_term>
	<mesh_term>Coenzyme Q10</mesh_term>
	<mesh_term>Ubiquinone</mesh_term>
	<criteria>Ages eligible study : 18 year old , 85 yea old Burn patient 5 % great total body surface area burn Nutrition support : routine oral and/or enteral nutrition Enrolled within one week burn injury Patient guardian capable give full inform consent . Anticipated stay MGH Burn Unit : 5 day &lt; 5 % TBSA burn Patients require full parenteral nutrition without oral enteral nutrition support . Patients liver disease ( bilirubin great 3 ) Patients thyroid disorder ( thyroid disease currently require treatment ) Patients malignancy treatment Patients mental illness impair decisionmaking capacity ( Mental illness define presence psychotropic medication and/or diagnosis psychiatric illness time admission . ) Patients mental illness include unless determine psychiatrist cover burn unit unable consent aspect care treatment . ) Patients HIV* Pregnancy ( determine routine admission lab )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>MGH</keyword>
	<keyword>Burn patient</keyword>
	<keyword>Adult</keyword>
	<keyword>CoQ10</keyword>
	<keyword>Ubiquinol</keyword>
</DOC>